Vuong K. Nguyen

8 Macquarie Street
Sydney, NSW 2000, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 113 publications

Flow cytometric assessment of measurable residual disease in acute myeloid leukaemia: a summary of current Australasian practice and future directions.

Flow cytometric assessment of measurable residual disease in acute myeloid leukaemia: a summary of current Australasian practice and future directions.

Journal: Internal medicine journal

Published: November 01, 2025

Detecting T-cell clones of uncertain significance using anti-TRBC1-based flow cytometry.

Detecting T-cell clones of uncertain significance using anti-TRBC1-based flow cytometry.

Journal: Pathology

Published: September 22, 2025

Computational flow cytometry reveals a high prevalence of TRBC1-restricted CD8+ T-cell subsets.

Computational flow cytometry reveals a high prevalence of TRBC1-restricted CD8+ T-cell subsets.

Journal: Leukemia & lymphoma

Published: March 31, 2025

Adherence to Anti-VEGF Treatment in Patients with Neovascular Age-Related Macular Degeneration: A Real-World Study.

Adherence to Anti-VEGF Treatment in Patients with Neovascular Age-Related Macular Degeneration: A Real-World Study.

Journal: Ophthalmology and therapy

Published: February 19, 2025

Impact of cataract surgery on patients receiving intravitreal therapy for retinal vein occlusion.

Impact of cataract surgery on patients receiving intravitreal therapy for retinal vein occlusion.

Journal: Clinical & experimental ophthalmology

Published: August 12, 2024

Longitudinal outcomes of iStent inject with cataract surgery compared with cataract surgery alone: real-world data from the Fight Glaucoma Blindness registry.

Longitudinal outcomes of iStent inject with cataract surgery compared with cataract surgery alone: real-world data from the Fight Glaucoma Blindness registry.

Journal: Journal of cataract and refractive surgery

Published: May 18, 2024

Twelve-Month Outcomes of Brolucizumab in Routine Clinical Practice: Fight Retinal Blindness! Registry.

Twelve-Month Outcomes of Brolucizumab in Routine Clinical Practice: Fight Retinal Blindness! Registry.

Journal: Clinical & experimental ophthalmology

Published: April 12, 2024

Immunophenotypic characterisation of acute myeloid leukaemia with UBTF tandem duplications.

Immunophenotypic characterisation of acute myeloid leukaemia with UBTF tandem duplications.

Journal: British journal of haematology

Published: February 03, 2024

Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice.

Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice.

Journal: Ophthalmology and therapy

Published: January 18, 2024

12-month Safety and Efficacy Outcomes of a Standalone Trabecular Bypass Device.

12-month Safety and Efficacy Outcomes of a Standalone Trabecular Bypass Device.

Journal: Journal of current glaucoma practice

Published: December 12, 2023

Three-Year Outcomes of VEGF Inhibitors in Naive Branch Retinal Vein Occlusion: Fight Retinal Blindness!

Three-Year Outcomes of VEGF Inhibitors in Naive Branch Retinal Vein Occlusion: Fight Retinal Blindness!

Journal: Ophthalmology. Retina

Published: October 30, 2023

Evaluation of T-cell clonality by anti-TRBC1 antibody-based flow cytometry and correlation with T-cell receptor sequencing.

Evaluation of T-cell clonality by anti-TRBC1 antibody-based flow cytometry and correlation with T-cell receptor sequencing.

Journal: British journal of haematology

Published: September 07, 2023

Showing 1-12 of 113

Last Updated: 09/26/2026